Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| SLC11A2 | α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson\'s Disease Models | ACS Chem Neurosci, 2020 Jun | Antibody | TA317307 |
| SLC11A2 | Hepcidin-to-Ferritin Ratio Is Decreased in Astrocytes With Extracellular Alpha-Synuclein and Iron Exposure | Front Cell Neurosci, 2020 Mar | Antibody | TA324527 |
| SLC11A2 | JWH133 inhibits MPP+-induced inflammatory response and iron influx in astrocytes | Neurosci. Lett., 2020 Jan | Antibody | TA324527 |
| SLC11A2 | Lactoferrin protects against iron dysregulation, oxidative stress, and apoptosis in MPTP-induced Parkinson's disease in mice | J. Neurochem., 2019 Aug | Antibody | TA324527 |
| SLC11A2 | Differential regulation of estrogen in iron metabolism in astrocytes and neurons | J. Cell. Physiol., 2018 Aug | Antibody | TA334160 |
| Slc12a5 | TGF-β2 Regulates Transcription of the K + /Cl − Cotransporter 2 (KCC2) in Immature Neurons and Its Phosphorylation at T1007 in Differentiated Neurons | Cells, 2022 Nov | Antibody | TA309219 |
| SLC12A5 | Effects of SPAK knockout on sensorimotor gating, novelty exploration, and brain area-dependent expressions of NKCC1 and KCC2 in a mouse model of schizophrenia | Prog. Neuropsychopharmacol. Biol. Psychiatry, 2015 Mar | Antibody | TA309219 |
| SLC16A1 | Critical Role of Neuronal Vps35 in Blood Vessel Branching and Maturation in Developing Mouse Brain | Biomedicines, 2022 Jul | Antibody | TA321556 |
| SLC16A1 | Linking cortical astrocytic neogenin deficiency to the development of Moyamoya disease-like vasculopathy | Neurobiology of disease, 2021 Mar | Antibody | TA321556 |
| SLC16A1 | Cyclosporine protects from intestinal epithelial injury by modulating butyrate uptake via upregulation of membrane monocarboxylate transporter 1 levels | Biochem Biophys Rep, 2020 Dec | Antibody | TA321555 |
| SLC16A1 | Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment | Sci Rep, 2019 Dec | Antibody | TA321555 |
| SLC16A1 | A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma | Vet Comp Oncol, 2019 Oct | Antibody | TA321555 |
| SLC17A6 | Optogenetic surface stimulation of the rat cervical spinal cord | J. Neurophysiol., 2018 May | Antibody | TA322266 |
| SLC17A7 | Molecular dissection of the valproic acid effects on glioma cells | Oncotarget, 2016 Sep | Antibody | TA322263 |
| SLC18A2 | Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris | Translational Neurodegeneration, 2021 Nov | Antibody | EUD2801 |
| SLC18A2 | Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment | PLoS ONE, 2019 Nov | Antibody | TA500506 |
| SLC18A2 | Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum | Neurochem. Int., 2019 Jan | Antibody | TA500506 |
| SLC18A2 | Methylphenidate alters monoaminergic and metabolic pathways in the cerebellum of adolescent rats | Eur Neuropsychopharmacol, 2018 Feb | Antibody | TA309861 |
| SLC18A2 | Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group | Eur. J. Nucl. Med. Mol. Imaging, 2015 Sep | Antibody | TA500506 |
| SLC18A2 | Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons | Nat. Neurosci., 2015 Feb | Antibody | AP16297PU-N |
| SLC18A2 | Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons | Nat. Neurosci., 2015 Feb | Antibody | AP16297PU-T |
| SLC18A2 | Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies | Journal of Cerebral Blood Flow & Metabolism (27 April 2011) doi:10.1038/jcbfm.2011.63 Original Article, 2011 Apr | Antibody | TA500506 |
| SLC18A2 | Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters. | Journal of neurochemistry, 2006 May | Antibody | EUD2801 |
| SLC1A2 | Ability of rat microglia to uptake extracellular glutamate | Neurosci. Lett., 2017 Jul | Antibody | AP54926SU-N |
| SLC1A2 | Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line | Eur. J. Neurosci., 2013 May | Antibody | AP54926SU-N |
| SLC1A2 | Decreased expression of glutamate transporters in genetic absence epilepsy rats before seizure occurrence | J. Neurochem., 2006 Mar | Antibody | AP54926SU-N |
| SLC22A5 | The Discovery of Highly Potent THP Derivatives as OCTN2 Inhibitors: From Structure-Based Virtual Screening to In Vivo Biological Activity | Int J Mol Sci, 2020 Oct | Antibody | TA327136 |
| SLC22A6 | Olsalazine sodium increases renal urate excretion by modulating urate transporters in hyperuricemic animals | Biol. Pharm. Bull., 2020 Aug | Antibody | TA322015 |
| SLC22A6 | Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition | Eur. J. Pharmacol., 2019 Jun | Antibody | TA322015 |
| SLC22A8 | Olsalazine sodium increases renal urate excretion by modulating urate transporters in hyperuricemic animals | Biol. Pharm. Bull., 2020 Aug | Antibody | TA321636 |
| SLC22A8 | Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition | Eur. J. Pharmacol., 2019 Jun | Antibody | TA321636 |
| SLC22A8 | Dual actions on gout flare and acute kidney injury along with enhanced renal transporter activities by Yokuininto, a Kampo medicine | BMC Complement Altern Med, 2019 Mar | Antibody | TA321636 |
| SLC25A13 | mRNA therapy improves metabolic and behavioral abnormalities in a murine model of citrin deficiency | Molecular Therapy, 2019 Apr | Antibody | TA332958 |
| SLC25A27 | Molecular dissection of the valproic acid effects on glioma cells | Oncotarget, 2016 Sep | Antibody | TA337004 |
| SLC25A42 | SLC25A42‐associated mitochondrial encephalomyopathy: Report of additional founder cases and functional characterization of a novel deletion | JIMD Reports, 2021 May | Antibody | TA334622 |
| SLC26A4 | Decreased Renal Expression of H(+)-ATPase and Pendrin in a Patient with Distal Renal Tubular Acidosis Associated with Sjögren's Syndrome | Intern. Med., 2018 Nov | Antibody | AM20191AF-N |
| SLC29A4 | Combined treatment of gemcitabine with indole-3-carbinol or metformin on drug efficacy in pancreatic cancer cell lines: The role of human equilibrative nucleoside transporters | J Cancer Res Ther., 2018 Feb | Antibody | TA350425 |
| SLC2A1 | Gene therapy for Glut1-deficient mouse using an adeno-associated virus vector with the human intrinsic GLUT1 promoter | J Gene Med, 2018 Apr | Antibody | TA301678 |
| SLC2A1 | Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome | Molecular Genetics and Metabolism Reports, 2017 Jan | Antibody | TA301678 |
| SLC2A1 | Toll like receptor mediated immune stimulation can be visualized in vivo by [18F]FDG-PET | Nuclear Medicine and Biology, 2016 Jul | Antibody | TA312796 |
| SLC2A10 | FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast | PLoS ONE, 2014 Nov | Antibody | AP07454PU-N |
| SLC2A4 | Olive Leaf Polyphenols (OLPs) Stimulate GLUT4 Expression and Translocation in the Skeletal Muscle of Diabetic Rats | International Journal of Molecular Sciences, 2020 Nov | Antibody | BP508 |
| SLC2A4 | Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome | Eur J Clin Nutr, 2018 Nov | Antibody | BP508 |
| SLC2A4 | Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats | Mol Med Rep, 2018 Oct | Antibody | BP508 |
| SLC2A4 | Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome. | Scandinavian journal of gastroenterology, 2018 Jun | Antibody | BP508 |
| SLC2A4 | Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome | BMC Gastroenterology, 2017 Aug | Antibody | BP508 |
| SLC2A4 | Abnormalities in endocrine and immune cells are correlated in dextran-sulfate-sodium-induced colitis in rats | Molecular Medicine Reports, 2017 Jan | Antibody | BP508 |
| SLC2A4 | Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis | International Journal of Molecular Medicine, 2016 Dec | Antibody | BP508 |
| SLC2A4 | Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome | Experimental and Therapeutic Medicine, 2016 Sep | Antibody | BP508 |
| SLC2A4 | Effects of AP-1 and NF-κB inhibitors on colonic endocrine cells in rats with TNBS-induced colitis | Molecular Medicine Reports, 2016 Aug | Antibody | BP508 |
Germany
Japan
United Kingdom
China